THE EFFECT OF DONOR CYTOMEGALOVIRUS (CMV) SEROLOGIC STATUS ON CMV REACTIVATION AND SURVIVAL IN PATIENTS UNDERGOING ALLOGENIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Vega, J. [1 ]
Vatca, M. [1 ]
Mikulandric, N. [1 ]
Neme, K. [1 ]
Hanbali, A. [1 ]
Janakiraman, N. [1 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.334
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
300
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [11] The importance of patient and donor CMV status in unrelated stem cell transplantation
    Shaw, BE
    Pay, AL
    Potter, MN
    Travers, P
    Mayor, N
    Prentice, HG
    Marsh, SGE
    Madrigal, JA
    BONE MARROW TRANSPLANTATION, 2002, 29 : S126 - S126
  • [12] Donor and recipient CMV status and the risk of CMV activation after allogeneic stem cell transplantation.
    Juvonen, E
    Ruutu, T
    Eriksson, B
    Remes, K
    Volin, L
    Remberger, M
    Parkkali, T
    Hägglund, H
    Ringdén, O
    BLOOD, 2001, 98 (11) : 396A - 396A
  • [13] CMV reactivation in pediatric hematopoietic stem cell transplantation
    Yoon, Hoi Soo
    Seo, Jong Jin
    Choi, Eun Seok
    Song, Joon Sup
    Im, Ho Joon
    Moon, Hyung Nam
    Park, Chan Jeoung
    Chi, Hyun Sool
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 502 - 502
  • [14] Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients
    Cui, Jiaqi
    Zhou, Yuhang
    Zhao, Kui
    Li, Xudong
    Zhang, Hanyue
    Zhang, Xiangzhong
    Sun, Yanling
    Long, Bing
    CLINICAL TRANSPLANTATION, 2024, 38 (04)
  • [15] CMV seropositive donor selection for CMV seropositive stem cell transplant recipients reduces CMV reactivation frequency and duration
    Cekauskiene, R.
    Maciutaite, E.
    Lizaitis, M.
    Simutiene, L.
    Trociukas, I.
    Griskevicius, L.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S178 - S178
  • [16] CYTOMEGALOVIRUS (CMV) REACTIVATION AND RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT
    Ramanathan, M.
    Cerny, J.
    Shanahan, L.
    Kroll, A.
    Nath, R.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S467 - S468
  • [17] High body mass index (BMI) does not have an adverse impact on cytomegalovirus [CMV] reactivation in patients undergoing allogeneic stem cell transplantation
    Murthy, V.
    Murray, D.
    Freeman, N.
    Paneesha, S.
    Nikolousis, M.
    Lovell, R.
    Kishore, B.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S332 - S332
  • [18] Donor CMV status influence on the outcome of allogeneic stem cell transplantation (HSCT)
    Ljungman, P.
    Brand, R.
    de la Camaro, R.
    Cordonnier, C.
    Einsele, H.
    Styczynski, J.
    Ward, K.
    Cesaro, S.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S54 - S55
  • [19] The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
    Grosso, Dolores
    Leiby, Benjamin
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    Gaballa, Sameh
    O'Hara, William
    Wagner, John L.
    Flomenberg, Neal
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [20] Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
    Débora C Dieamant
    Sandra HA Bonon
    Renata MB Peres
    Claudia RC Costa
    Dúlcinéia M Albuquerque
    Eliana CM Miranda
    Francisco JP Aranha
    Gislaine Oliveira-Duarte
    Virginio CA Fernandes
    Carmino A De Souza
    Sandra CB Costa
    Afonso C Vigorito
    BMC Infectious Diseases, 13
12345